YFile - Symposium examines the path to breakthrough medicines - 0 views
-
Canada has the research expertise to develop drugs and vaccines to address pressing medical needs, but delivering on the promise will require new models of collaboration between scientists, biotechnology, the pharmaceutical industry, business and policy makers according to speakers at an upcoming symposium hosted by The Gairdner Foundation and York University. The symposium, Entrepreneurship & Commercialization in Biomedical Science, on Thursday, May 14, marks the 50th anniversary of both York University and The Gairdner Foundation.
-
The Gairdner Foundation recognizes the world's leading medical research scientists through its prestigious annual awards program for biomedical science. The symposium, which is hosted by York’s Faculty of Science & Engineering and Schulich School of Business, will bring together scientist entrepreneurs, Canadian venture capital firms, the biomedical industry and policy-makers.
-
He will be followed by Smith, founder and former president & CEO of RBC Ventures and a member of the board of Toronto's MaRS innovation centre. Smith will speak about how Canada has made strong progress in positioning itself as a potential leader in biotech and medical research and in its commercialization efforts but faces two clear threats – the global financial calamity together with the lack of clear federal government support for research.
-
The symposium, Entrepreneurship & Commercialization in Biomedical Science, is being held on Thursday, May 14, which marks the 50th anniversary of both York University and The Gairdner Foundation. At this symposiums they will address the problem that Canadian researchers expertise to need to do in developing drugs and vaccines to address pressing medical needs. Mention of Susan Smith as a Board Member of MaRS Innovation.